MedTrace Logo

"Me and My Heart" Study

NCT02615704 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 677

Last updated 2020-06-04

No results posted yet for this study

Summary

An electronic device application (APP) "Mein Herz und ich" has been developed specifically for acute coronary syndrome (ACS) patients who are prescribed to Brilique (ticagrelor) to increase adherence to treatment (medication and lifestyle changes) by a combination of reminders on medication intake, information on the importance of treatment, motivation by supportive messages, and visualisation of individual lifestyle choices' effect on cardiovascular risk. The aim of this study is to evaluate the effectiveness of this patient support tool

Conditions

  • Acute Coronary Syndrome

Interventions

DEVICE

Active group without MEMS

Patients treated with twice daily Brilique (ticagrelor) co administered with low dose of acetylsalicylic acid with APP as support tool but without MEMS

DEVICE

Control group with MEMS

Patients treated with twice daily Brilique (ticagrelor) co administered with low dose of acetylsalicylic acid without APP as support tool but with MEMS

DEVICE

Control group without MEMS

Patients treated with twice daily Brilique (ticagrelor) co administered with low dose of acetylsalicylic acid without APP as support tool and without MEMS

DEVICE

Active group with MEMS

Patients treated with twice daily Brilique (ticagrelor) co administered with low dose of acetylsalicylic acid with APP as support tool and with MEMS

Sponsors & Collaborators

Principal Investigators

  • Florian Krackhardt, MD · Charite University, Berlin, Germany

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-11
Primary Completion
2019-03-07
Completion
2019-03-07

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02615704 on ClinicalTrials.gov